In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reimbursement: The New Biopharma Investment Hurdle

Executive Summary

With a growing number of expensive therapeutics entering the market and rising pressures to contain costs, gauging reimbursement is now a crucial element deal makers must evaluate.
Advertisement

Related Content

Bridging The Gap Between Sell- And Buy- Sides In Biopharma Business Development
Pharma: Serious About Change?
Exploring the Full Potential of Risk-Sharing Agreements Between Pharma Companies and Payors
Exploring the Full Potential of Risk-Sharing Agreements Between Pharma Companies and Payors
Building A Biopharma Product's Reimbursement Into Deals
Building A Biopharma Product's Reimbursement Into Deals
Pharma's New Follow-On Strategy
Pharma's New Follow-On Strategy
NitroMed's BiDil Pricing: Test for a Whole Class of New Companies
NitroMed's BiDil Pricing: Test for a Whole Class of New Companies

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel